management

Cardiff Oncology, Inc. (CRDF) has a defined executive management team responsible for its operations and strategic direction.

Key members of Cardiff Oncology's executive team include:

• Mark Erlander, Ph.D. serves as the Chief Executive Officer (CEO).
• Roger Sidhu, MD was appointed as the Chief Medical Officer (CMO) on June 17, 2025, succeeding Dr. Fairooz Kabbinavar, who remains with the company in an advisory role.
• James Levine holds the position of Chief Financial Officer (CFO).
• Tod Smeal, Ph.D. is the Chief Scientific Officer (CSO).

The company's Board of Directors includes Dr. Rodney Markin as Chairman, and other directors such as Dr. James O. Armitage, Mani Mohindru, Ph.D., Gary W. Pace, Ph.D., Renee P. Tannenbaum, Pharm.D., and Lâle White. The separation of the CEO and Board Chair roles allows the CEO to focus on day-to-day business while the Chair provides independent oversight.